Full CoverageRegulators Approve Lenacapavir for H.I.V. Prevention
By Apoorva Mandavilli
Top news
HIV prevention drug hailed as a 'breakthrough' gets FDA approval : Goats and Soda
By Jonathan Lambert
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
By Annika Kim Constantino
FDA approves powerful HIV prevention drug: What to know about Yeztugo
By Benjamin Ryan
Posts on X
Formerly Twitter
Gilead Sciences
GileadSciences
#InTheNews: Earlier today, we received FDA approval for our #HIV prevention medication. Read more on this milestone moment in our mission to help end the HIV epidemic: gilead.inc/4eaEiUO pic.x.com/PJeUDLm1H0
Posted on X
Gilead Sciences
GileadSciences
#InTheNews: In light of our recent #HIV announcement, hear how community advocates feel about the importance of prevention. pic.x.com/YHJJ5VHg37
Posted on X
UNAIDS Global
UNAIDS
✍️@Guardian | Lenacapavir, twice-yearly HIV prevention injection could cost just $25 per patient a year, say researchers—yet may be priced at 1000x more.
This medicine could help end the HIV pandemic.
We urge @GileadSciences: Do the right thing. Make it affordable. Save lives.
Posted on X
Frontline AIDS
frontlineaids
A drug with the potential to “end the #HIV pandemic” will launch in the US this week.
We join @UNAIDS @Winnie_Byanyima's call to "make #lenacapavir available & affordable for all who need it."
Read the latest by @katlay from the @guardian ⤵️
www.theguardian.com/society/2025/jun/17/hiv-ending-drug-lenacapavir-manufacture-cost-per-patient-gilead
Posted on X
All coverage
The world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it
By Lauran Neergaard
Gilead’s Twice-a-Year HIV Prevention Shot Wins US FDA Approval
By Robert Langreth
US FDA approves Gilead's twice-yearly injection for HIV prevention
By Deena Beasley & Julie Steenhuysen
FDA Approves Gilead’s HIV Shot. It Works 99.9% of the Time.
By Josh Nathan-kazis
HIV protection with just two shots a year: FDA approves Gilead drug
By Jason Mast & Ed Silverman
FDA signs off on Gilead's landmark long-acting PrEP med, signaling new era in HIV prevention
By Zoey Becker
FDA approves new twice-yearly HIV shot. What to know
By Ken Alltucker
FDA approves twice-a-year injection for HIV prevention
By Jacqueline Howard
FDA Approves “Breakthrough” HIV Drug
By Jackie Flynn Mogensen & Jackie Flynn
FDA approves 6-month HIV prevention shot
By Joseph Choi
Lenacapavir Approval Could Change Course of Treating, Preventing HIV: Gordon Crofoot, MD, PA
By Julia Bonavitacola
FDA approves ‘life-saving’ HIV prevention shot
By Alani Letang, M.A.
FDA Approves Lenacapavir for Prevention of HIV
By Killian Meara
FDA approves new, twice-yearly injection for HIV prevention
By Samuel Carrico
Will Big Pharma Greed Consume Promise of 'HIV-Ending' Shot?
By Jessica Corbett
Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent
By Peter Wehrwein
FDA approves long-lasting HIV-prevention drug
By Mike Heuer
The world's only twice-a-year shot to prevent HIV could stop transmission -- if people can get it
By Lauran Neergaard
Long-acting HIV prevention drug from Gilead wins FDA approval. Will it get to the people who need it?
By Ron Leuty
FDA Approves Powerful Twice-Yearly Treatment to Prevent HIV
By Joseph Walker & Peter Loftus
FDA approves twice-yearly lenacapavir PrEP
By Liz Highleyman
FDA approves the world's only twice-a-year shot to prevent HIV
By Lauran Neergaard
FDA approves twice-a-year injection for HIV prevention
By Jacqueline Howard
The world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it
By Lauran Neergaard
The world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it
By Lauran Neergaard
Gilead stock gains on FDA nod for HIV PrEP drug (GILD:NASDAQ)
By Dulan Lokuwithana
The world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it
By Lauran Neergaard
The world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it
By Lauran Neergaard
FDA Approves a Twice-Yearly Shot to Prevent HIV
By Alice Park